Evolving Trends in Surgical Management of Breast Cancer: An Analysis of 30 Years of Practice Changing Papers

Abstract

The management of breast cancer has evolved into a multidisciplinary evidence-based surgical speciality, with emphasis on conservative surgery. A number of landmark trials have established lumpectomy followed by radiation as the standard of care for many patients. The aim of this study is to construct a narrative review of recent developments in the surgical management of breast cancer and how such developments have impacted surgical practice. A comprehensive literature search of Pubmed was conducted. The latest search was performed on October 31st, 2020. Search terms “breast cancer” were used in combinations with specific key words and Boolean operators relating to surgical management. The reference lists of retrieved articles were comprehensively screened for additional eligible publications. Articles were selected and reviewed based on relevance. We selected publications in the past 10 years but did not exclude commonly referenced and highly regarded previous publications. Review articles and book chapters were also cited to provide reference on details not discussed in the academic literature. This article reviews the current evidence in surgical management of early-stage breast cancer, discusses recent trends in surgical practice for therapeutic and prophylactic procedures and provides commentary on implications and factors associated with these trends.

The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment

“…In response to the constantly increasing cases of breast cancer, a huge effort has been made to encourage more frequent and easily accessible breast cancer screenings, as well as to find new and more effective diagnostic and treatment strategies [ 3 , 4 ]. Several treatments have been proposed for breast cancer [ 5 , 6 , 7 ], namely surgery [ 8 , 9 ], radiation [ 10 ] and/or chemotherapy [ 11 ], immunotherapy [ 7 ], hormone therapy [ 5 , 11 ] and targeted therapy [ 12 ]. Nevertheless, the outcomes of the currently available strategies are still typically associated with high impact both on patient’s life and self-esteem [ 13 ], and/or lack of specificity towards cancerous cells, which increases the chance of suffering from extensive adverse side effects [ 14 ].…”

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis

“…Breast cancer is the most frequently diagnosed malignancy in women, with a lifetime risk of 12.4% in the western world [ 1 ]. While surgical resection through Halsted’s radical mastectomy was once considered the cornerstone of breast cancer management, novel therapeutic strategies and a more targeted approach to surgery have facilitated the improved oncological and survival outcomes, while minimizing treatment-related morbidity [ 2 ]. These timely changes to breast cancer care coincide with our heightened appreciation for the cellular, biomolecular, and genomic properties responsible for driving oncogenesis [ 3 , 4 ].…”

Long-term oncological outcomes of oncoplastic breast-conserving surgery after a 10-year follow-up – a single center experience and systematic literature review

“…Historical data have shown that breast-conserving surgery followed by radiotherapy has equivalent oncological outcomes to those of mastectomy in early breast cancer ( 1 , 2 ). As long-term survival after breast cancer treatment has become commonplace, more attention has been given to develop oncoplastic techniques to provide better patient and aesthetic satisfaction ( 3 , 4 ). The primary role of oncoplastic breast-conserving surgery (OBCS) is to achieve oncological safety while minimizing the risk of unacceptable local deformity by allowing reconstruction of the defect and preventing the need for mastectomy ( 5 , 6 ).…”